Registration and welcome
7.45-8.00 am: Assemble committee and speakers for session 1
8.00-8.10 am: Welcome
Anatoly Rozenfeld, Michael Lerch, and Tomas Kron
8.10-8.20 am: Official Opening of MMND
Alan Rowan, Deputy Vice-Chancellor (Research and Innovation), University of Wollongong, Australia
Session 1: Spatially fractionated radiation therapy (SFRT)
Session Chairs: Valentin Djonov, Olga Martin
- 8.20-8.40 am: Dosimetry for SFRT: MRT and X-ray mini-beam
Michael Lerch | CMRP, University of Wollongong, Australia - 8.40-9.00 am: SFRT: Current status and clinical implementation
Valentin Djonov | University of Bern, Switzerland - 9.00-9.20 am: Clinical Minibeam experience at Mayo Clinic
Sean Park | Mayo Clinic Rochester, USA - 9.20-9.40 am: Bringing MRT to patients: A road paved by paper, plastic and good intentions
Thomas Breslin | Lund University, Sweden - 9.40-9.55 am: Sub-millimetre SFRT: A new frontier in radiation-induced anti-tumour immunity
Verdiana Trappetti | University of Bern, Switzerland - 9.55-10.10 am: Weeks, Not Hours: Synchrotron microbeam radiotherapy induces a persistent blood–brain barrier permeability window in normal mouse brain
Christian Fernandez | University of Bern, Switzerland - 10.10-10.30 am: TBC
Elisabeth Schültke | Rostock University Medical Center, Germany
10.30-11.00 am: Morning tea and industry exhibition
Session 2: Spatially fractionated radiation therapy (SFRT) continued
Session Chairs: Tomas Kron, Stéphanie Corde
- 11.00-11.20 am: Immune responses underlying the abscopal effect triggered by microbeam radiotherapy in a preclinical non-immunogenic tumour model
Olga Martin | CMRP, University of Wollongong, Australia - 11.20-11.35 am: Microbeams un-leashed: promising outcomes for canine sarcoma treated with microbeam radiation therapy
Elette Engels | Peter MacCallum Cancer Centre, Australia - 11.35-11.55 am: The first clinical microbeam source in Munich
Stefan Bartzsch | Technical University of Munich, Germany - 11.55 am-12.15 pm: X-ray source prototype and grid manufacturing for sub-mm SFRT
Martin Braeuer | Siemens Healthineers AG, Germany
12.15-1.30 pm: Lunch and industry exhibition
Session 3: Particle Therapy - Physics and Planning
Session Chairs: Linh Tran, Carl Rossi
- 1.30-1.50 pm: Current status and future perspectives of charged-particle therapy
Taku Inaniwa | National Institute for Quantum Science and Technology, Chiba, Japan - 1.30-2.10 pm: Radiobiology modelling – How do we crack it?
Erik Traneus | RaySearch, Sweden - 2.10-2.30 pm: Dr Calc is back: updated results from dose rate calculations in PBS
Nicolas Depauw | Massachusetts General Hospital, USA - 2.30-2.50 pm: Advanced on-board imaging for precision small animal proton and light ion radiation research
Andrew Wroe | Miami Cancer Institute, Miami, USA - 3.10-3.25 pm: TBC
Suresh Rana |Lynn Cancer Institute - Boca Raton Regional Hospital Boca Raton, Florida, USA
3.25-3.45 pm: Afternoon tea and industry exhibition
Session 4: New Era for BNCT
Session Chairs: Mitra Safavi-Naeni, James Vohradsky
- 3.45-4.10 pm: BNCT: Past, present, and future
Chad Lee, Vice President, Product at TAE LifeSciences - 4.10-4.25 pm: NCEPT- current status and future
Mitra Safavi-Naeni | ANSTO, Australia - 4.25-4.40 pm: Current Status of research and development using the Linac-Based BNCT system at Tsukuba University
Hiroaki Kumada | University of Tsukuba, Japan - 4.40-4.55 pm: Ultra-high-current lithium and carbon ion beams by direct plasma injection: a compact driver for accelerator-based BNCT
Masahiro Okumura |Brookhaven National Laboratory, USA - 4.55-5.05 pm: Advancing Clinical BNCT: Technological developments in accelerator-based BNCT system
Naonori Hu | Kansai BNCT Medical Center, Japan - 5.05-5.15 pm: Application of SOI microdosimetry in BNCT
James Vohradsky | CMRP, University of Wollongong, Australia
6.00-8.00 pm: Welcome reception at Mantra Mooloolaba Beach - Harbour Room